| # | Side effect | Count |
|---|---|---|
| 0 | PRODUCT DOSE OMISSION ISSUE | 354 |
| 1 | INJECTION SITE PAIN | 160 |
| 2 | INJECTION SITE HAEMORRHAGE | 142 |
| 3 | DRUG INEFFECTIVE | 111 |
| 4 | OFF LABEL USE | 100 |
| 5 | INJECTION SITE MASS | 61 |
| 6 | FATIGUE | 57 |
| 7 | INJECTION SITE BRUISING | 56 |
| 8 | ACCIDENTAL EXPOSURE TO PRODUCT | 53 |
| 9 | PRODUCT DOSE OMISSION | 52 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | SECONDARY HYPOGONADISM | 9 | 0.0273 |
| 1 | BLOOD TESTOSTERONE INCREASED | 14 | 0.0065 |
| 2 | FOCAL SEGMENTAL GLOMERULOSCLEROSIS | 10 | 0.0062 |
| 3 | POLYCYTHAEMIA | 12 | 0.0058 |
| 4 | HAEMATOCRIT INCREASED | 10 | 0.0044 |
| 5 | BLOOD TESTOSTERONE DECREASED | 20 | 0.0029 |
| 6 | BLOOD CULTURE POSITIVE | 8 | 0.0027 |
| 7 | ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS | 19 | 0.0024 |
| 8 | STREPTOCOCCAL INFECTION | 12 | 0.0022 |
| 9 | PRODUCT TEMPERATURE EXCURSION ISSUE | 11 | 0.0021 |